OmniSeq
Healthcare Services · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
700 Ellicott St, Buffalo, New York, 1420...Phone Number
(800) 781-1259Website
www.omniseq.comRevenue
$22.2 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
4
2
2
2
2
About OmniSeq
OmniSeq, an innovation of Roswell Park Comprehensive Cancer Center, is a molecular diagnostic laboratory based in Buffalo, N.Y. OmniSeq endeavors to find the right drug or the right trial for every patient by improving access to better cancer treatment options through genomic and immune profiling. OmniSeq offers three NGS-based assays: OmniSeq MSI NGS®, OmniSeq Advance®, and OmniSeq Comprehensive®.Explore more
OmniSeq Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OmniSeq your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when OmniSeq launches new products
Congratulate Masked Content for being promoted to Masked Content at OmniSeq
OmniSeq, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if OmniSeq is spiking on competitors!
Earning: See what the market has to say on OmniSeq recently announced quarterly report
Check if OmniSeq has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once OmniSeq has new funding data
Click to see if OmniSeq had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined OmniSeq as Masked Content
Find more new buyers
Compare Similar Companies to OmniSeq
Compare insights from companies similar to OmniSeq, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OmniSeq
$22.2M
51-200
Private
$10M
2015
AD
Alicia DillardAssociate Clinical Laboratory Director and Molecular Pathologist
Company Profile Activity
Activity Insights
OmniSeq is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
OmniSeq is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about OmniSeq.
OmniSeq financials insights
Gather financial insights about OmniSeq, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$10M
OmniSeq Tech Stack
A closer look at the technologies used by OmniSeq
See more technologies
Most Recent Scoops
New Hire
Executive Move
Project
OmniSeq has expressed interest in implementing quality assurance for related quality control projects.
Implementation, Quality Assurance, Request for Proposal (RFP)
Funding
, a medical services company, recently secured $1.57 million in funding.
Funding
Funding
, a medical services company, recently secured $7.33 million in funding.
Funding
Open Position
Seeking Replacement, Personnel Moves
OmniSeq News & Media
Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology
BUFFALO, N.Y., June 14, 2021 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, and OmniSeq, a CAP-accredited, molecular diagnostic innovation of Roswell Park Comprehensive Cancer Center, today announced the launch of OmniSeq INSIGHT℠, a comprehensive genomic and...OmniSeq Receives New York State Approval for OmniSeq INSIGHT Genomic and Immune Profiling Test
BUFFALO, N.Y., April 28, 2021 /PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing in oncology, today announced the New York State Department of Health's Clinical Laboratory Evaluation Program has approved the OmniSeq INSIGHTSM test. The test detects genomic variants,...OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical Study
BUFFALO, N.Y., Jan. 28, 2021 /PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing in oncology, today announced its collaboration with the University of Pittsburgh Medical Center (UPMC) to employ its RNA sequencing (RNA-seq) gene expression profile assay for selecting...OmniSeq Receives ISO Certification for Quality Management Systems
BUFFALO, N.Y., Dec. 1, 2020 /PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing (NGS) in oncology, today announced the company has received the International Organization for Standards (ISO) 13485:2016 certification for its Quality Management Systems (QMS). ISO 13485:2016...
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OmniSeq
Sign Up For FreeTo access detailed company insights
OmniSeq, an innovation of Roswell Park Comprehensive Cancer Center, is a molecular diagnostic laboratory based in Buffalo, N.Y. OmniSeq endeavors to find the right drug or the right trial for every patient by improving access to better cancer treatment options through genomic and immune profiling. OmniSeq offers three NGS-based assays: OmniSeq MSI... Read More
